Botulism¶
Chapter 158 | Part 5: Infectious Diseases
KEY CLINICAL POINTS¶
- Botulism is a rare, life-threatening paralytic illness caused by botulinum neurotoxins (BoNTs) from Clostridium botulinum, C. butyricum, and C. baratii.
- Four main forms: foodborne (most common in the U.S.), infant, wound, and adult intestinal colonization; iatrogenic and inhalational botulism are also recognized.
- Early administration of botulinum antitoxin (BAT) and supportive care are critical; mortality is significantly reduced with prompt treatment.
1. DEFINITION & OVERVIEW¶
Botulism is a rare, life-threatening disease characterized by cranial nerve palsies and symmetric descending flaccid paralysis. It is caused by botulinum neurotoxins (BoNTs) produced by Clostridium botulinum, C. butyricum, and C. baratii. Four naturally occurring forms include foodborne, infant, wound, and adult intestinal colonization. Other forms include iatrogenic botulism (from BoNT injections) and inhalational botulism (bioweapon use).
Table 158-1: Total Foodborne Botulism Outbreaks of 10 or More Cases Reported in the United States Between 2001 and 2019¶
| YEAR | STATE | FOOD SOURCE | NO. OF CONFIRMED CASES |
|---|---|---|---|
| 2001 | Texas | Chili | 16 |
| 2001 | Multistate | Commercially canned hot dog chili sauce | |
| 2015 | Ohio | Home-canned potatoes used to prepare a potato salad, served at a church potluck | 27 |
| 2015 | Mississippi | Pruno, illegal alcoholic beverage consumed by persons incarcerated at a federal facility | 19 |
| 2017 | California | Commercially produced nacho cheese, sold at a convenience store | 10 |
1.1 Botulinum Neurotoxins (BoNTs)¶
BoNTs are metalloproteases composed of a light chain (catalytic) and heavy chain (receptor-binding and translocation domains). They cleave SNARE proteins (SNAP-25, VAMP, syntaxin) to block neurotransmission, causing flaccid paralysis. Seven serotypes (A–G) are well-characterized; serotypes A, B, E, and F cause human disease.
1.2 Toxin Mechanism¶
BoNTs bind to neuronal gangliosides via the heavy chain, enter via endocytosis, and the light chain cleaves SNARE proteins, disrupting synaptic vesicle fusion. Irreversible paralysis occurs until nerve regeneration (weeks–months).
2. EPIDEMIOLOGY¶
Foodborne botulism is the third most common form in the U.S., with 362 cases reported (2001–2019). Serotype A (64%) and E (26%) are most common. Wound botulism (second most common) increased due to injection drug use (black tar heroin). Infant botulism affects infants ≤ 1 year, with ~2172 cases (2001–2019). Adult intestinal colonization is rare but linked to immunosuppression or antibiotic use.
2.1 Foodborne Botulism¶
Most cases from home-canned vegetables (green beans, potatoes, beets), commercial foods (chili sauce, canned goods), and marine products. Outbreaks often involve 10+ cases; 5 outbreaks reported (2001–2019).
2.2 Wound Botulism¶
Linked to injection drug use (black tar heroin) and traumatic injuries. 452 cases reported (2001–2019), 92% serotype A or B. 96% of cases involved drug injectors.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
BoNTs are produced by C. botulinum (and rare strains of C. butyricum/C. baratii). Spores survive heat and are ubiquitous in soil, water, and food. Germination occurs in anaerobic environments (e.g., improperly canned foods). Toxins cleave SNARE proteins (SNAP-25, VAMP, syntaxin), blocking acetylcholine release and causing flaccid paralysis. BoNTs are heat-resistant and require retort canning for destruction.
3.1 Toxin Structure¶
BoNTs are 150-kDa proteins with a light chain (catalytic) and heavy chain (receptor-binding/translocation). Heavy chain mediates neurospecific binding; light chain cleaves SNARE proteins. Serotypes A and E cleave SNAP-25; B, D, F, G cleave VAMP; C cleaves SNAP-25 and syntaxin.
3.2 Spore Survival¶
Spores are heat-resistant (require >100°C for destruction). Low-acidity foods (e.g., corn, peppers) and improperly canned goods are high-risk. Commercial retort canning reliably destroys spores.
4. CLINICAL FEATURES¶
Symptoms include ptosis, diplopia, dysarthria, facial droop, and descending flaccid paralysis. Incubation period: 6 h–7 days (average 1–2 days). Respiratory failure occurs in 42% of cases. Neurologic examination reveals cranial nerve palsies (III, IV, VI, VII) and symmetric paralysis. Patients are fully conscious but paralyzed ("locked-in" state).
4.1 Presentation¶
Bilateral cranial nerve palsies (III, IV, VI, VII) followed by descending paralysis. Ptosis, dysarthria, and facial droop are hallmark signs. Respiratory compromise occurs in 42% of cases, requiring intubation.
4.2 Differential Diagnosis¶
Differentiate from Guillain-Barré syndrome (ascending paralysis), myasthenia gravis (fatigable weakness), Lambert-Eaton syndrome (proximal weakness), and tick paralysis. Clinical context and neurologic exam are critical.
5. DIFFERENTIAL DIAGNOSIS¶
Guillain-Barré syndrome (GBS), myasthenia gravis, Lambert-Eaton syndrome, tick paralysis, tetrodotoxin poisoning, and antimicrobial-associated paralysis. GBS presents with ascending paralysis; myasthenia gravis has fatigable weakness; Lambert-Eaton shows proximal weakness in cancer patients. CSF protein elevation is seen in GBS but not botulism.
5.1 Key Differentiators¶
Botulism: cranial nerve palsies + descending paralysis, no sensory deficits, no CSF protein elevation. GBS: ascending paralysis, CSF protein elevation. Myasthenia gravis: fatigable weakness, Tensilon test. Lambert-Eaton: proximal weakness in cancer patients.
6. INVESTIGATIONS & DIAGNOSIS¶
Diagnosis requires clinical suspicion and laboratory confirmation. Mouse bioassay (gold standard) detects BoNT in serum/stool. Endopep-MS assay identifies active BoNT. PCR detects bont genes (A–G). Clinical criteria include bilateral cranial palsies, descending paralysis, and no sensory deficits. CDC guidelines recommend contacting state health departments for BAT availability.
6.1 Diagnostic Tests¶
Mouse bioassay (sensitive but animal use), Endopep-MS (rapid, no animals), PCR (screening for bont genes), and CSF analysis (normal in botulism). Lumbar puncture may confirm normal CSF in GBS.
6.2 Clinical Criteria¶
Bilateral cranial nerve palsies, descending flaccid paralysis, and no sensory deficits. Outbreaks are pathognomonic. Early suspicion is critical to initiate antitoxin therapy.
7. MANAGEMENT & TREATMENT¶
Immediate supportive care (intubation, ventilator support) and antitoxin (BAT or BabyBIG). Antitoxin neutralizes unbound toxin but does not reverse existing paralysis. Mechanical ventilation is required in 42% of cases. Prophylactic antibiotics are not recommended. Rehabilitation is needed for prolonged paralysis.
7.1 Antitoxin Therapy¶
Equine-derived BAT (for noninfant botulism) and human-derived BabyBIG (infant botulism). Administer as soon as possible (within 48 h of symptoms). BAT neutralizes toxin but does not reverse paralysis. Dose: 1 vial (10,000 U) for adults; BabyBIG: 1 vial for infants.
7.2 Supportive Care¶
Intensive care for respiratory support, prevention of ventilator-associated pneumonia, decubitus ulcers, and psychological trauma. Nutritional support and rehabilitation are critical for recovery.
8. PROGNOSIS & COMPLICATIONS¶
Mortality <5% with prompt treatment. Complications include respiratory failure, pneumonia, ulcers, and psychological trauma. Most patients recover within weeks–months. Severe cases may require prolonged ICU stays. Infant botulism has near 100% survival rate with BabyBIG.
9. SPECIAL CONSIDERATIONS¶
Prevention: safe canning (retort methods), avoiding honey in infants (<1 year), and safe injection practices for drug users. Vaccination is not available. Pruno (illegal alcohol) is a risk for prison outbreaks. Wound botulism linked to traumatic injuries requires wound cleaning. Infant botulism is managed with BabyBIG and supportive care.
9.1 Prevention Strategies¶
Home canning guidelines (USDA), refrigeration of garlic/herb-infused oils, and avoiding honey in infants. Safe injection practices reduce wound botulism risk. Public health education is critical for high-risk groups.
9.2 Special Populations¶
Infants: avoid honey; adults: safe canning; drug users: safe injection practices. Pregnant women may experience similar symptoms to nonpregnant individuals.
10. KEY POINTS & CLINICAL PEARLS¶
- Botulism is a medical emergency requiring immediate antitoxin and ventilatory support. 2. Four main forms: foodborne (most common), infant, wound, and adult intestinal. 3. Early administration of BAT (within 48 h) reduces mortality. 4. Avoid honey in infants to prevent botulism. 5. Use CDC guidelines for clinical suspicion and public health reporting.